These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2052 related items for PubMed ID: 27312681
1. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis? Lee SH, Kim BJ, Han MK, Park TH, Lee KB, Lee BC, Yu KH, Oh MS, Cha JK, Kim DH, Nah HW, Lee J, Lee SJ, Ko Y, Kim JG, Park JM, Kang K, Cho YJ, Hong KS, Choi JC, Kim JT, Choi K, Kim DE, Ryu WS, Kim WJ, Shin DI, Yeo M, Lee J, Lee JS, Gorelick PB, Bae HJ. Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681 [Abstract] [Full Text] [Related]
2. Remote Intracerebral Hemorrhage After Intravenous Thrombolysis: Results From a Multicenter Study. Prats-Sánchez L, Camps-Renom P, Sotoca-Fernández J, Delgado-Mederos R, Martínez-Domeño A, Marín R, Almendrote M, Dorado L, Gomis M, Codas J, Llull L, Gómez González A, Roquer J, Purroy F, Gómez-Choco M, Cánovas D, Cocho D, Garces M, Abilleira S, Martí-Fàbregas J, Catalan Stroke Code and Reperfusion Consortium (Cat-SCR). Stroke; 2016 Aug; 47(8):2003-9. PubMed ID: 27406103 [Abstract] [Full Text] [Related]
3. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST. Flint AC, Gupta R, Smith WS, Kamel H, Faigeles BS, Cullen SP, Rao VA, Bath PM, Wahlgren N, Ahmed N, Donnan GA, SITS International and VISTA-plus investigators. Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855 [Abstract] [Full Text] [Related]
4. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours. Thomalla G, Sobesky J, Köhrmann M, Fiebach JB, Fiehler J, Zaro Weber O, Kruetzelmann A, Kucinski T, Rosenkranz M, Röther J, Schellinger PD. Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683 [Abstract] [Full Text] [Related]
5. Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008-2012. Tong X, George MG, Yang Q, Gillespie C. Int J Stroke; 2014 Aug; 9(6):728-34. PubMed ID: 24024962 [Abstract] [Full Text] [Related]
6. Remote or extraischemic intracerebral hemorrhage--an uncommon complication of stroke thrombolysis: results from the safe implementation of treatments in stroke-international stroke thrombolysis register. Mazya MV, Ahmed N, Ford GA, Hobohm C, Mikulik R, Nunes AP, Wahlgren N, Scientific Committee of SITS International. Stroke; 2014 Jun; 45(6):1657-63. PubMed ID: 24788971 [Abstract] [Full Text] [Related]
7. Computed Tomography--Verified Leukoaraiosis Is a Risk Factor for Post-thrombolytic Hemorrhage. Willer L, Havsteen I, Ovesen C, Christensen AF, Christensen H. J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1126-30. PubMed ID: 25920756 [Abstract] [Full Text] [Related]
8. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions. Seet RC, Rabinstein AA. Cerebrovasc Dis; 2012 Jun; 34(2):106-14. PubMed ID: 22868870 [Abstract] [Full Text] [Related]
9. Severe renal impairment is associated with symptomatic intracerebral hemorrhage after thrombolysis for ischemic stroke. Tütüncü S, Ziegler AM, Scheitz JF, Slowinski T, Rocco A, Endres M, Nolte CH. Stroke; 2013 Nov; 44(11):3217-9. PubMed ID: 24003042 [Abstract] [Full Text] [Related]
10. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. Wolfe T, Suarez JI, Tarr RW, Welter E, Landis D, Sunshine JL, Zaidat OO. J Stroke Cerebrovasc Dis; 2008 Nov; 17(3):121-8. PubMed ID: 18436152 [Abstract] [Full Text] [Related]
11. Intravenous Thrombolysis in Unknown-Onset Stroke: Results From the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry. Dorado L, Ahmed N, Thomalla G, Lozano M, Malojcic B, Wani M, Millán M, Tomek A, Dávalos A. Stroke; 2017 Mar; 48(3):720-725. PubMed ID: 28174326 [Abstract] [Full Text] [Related]
12. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study. Aoki S, Hosomi N, Sueda Y, Kono T, Takamatsu K, Ohyama H, Torii T, Kitamura T, Nomura E, Noda K, Ohtsuki T, Matsumoto M, HARP Registry Study Group. J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2747-53. PubMed ID: 26360972 [Abstract] [Full Text] [Related]
13. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke? Hassan AE, Chaudhry SA, Jani V, Grigoryan M, Khan AA, Adil MM, Qureshi AI. J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555 [Abstract] [Full Text] [Related]
14. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study. Saqqur M, Shuaib A, Alexandrov AV, Sebastian J, Khan K, Uchino K. Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252 [Abstract] [Full Text] [Related]
15. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage. Vandelli L, Marietta M, Gambini M, Cavazzuti M, Trenti T, Cenci MA, Casoni F, Bigliardi G, Pentore R, Nichelli P, Zini A. J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):394-400. PubMed ID: 25497721 [Abstract] [Full Text] [Related]
16. Safety and Efficacy of Intravenous Low-Dose Alteplase in Relative Contraindication Patients with Acute Ischemic Stroke. Ohta T, Okada K, Fukuda M, Masahira N, Matsuoka T, Tsuno T, Takemura M. J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1844-1851. PubMed ID: 29555402 [Abstract] [Full Text] [Related]
17. Posterior vs. anterior circulation infarction: demography, outcomes, and frequency of hemorrhage after thrombolysis. Dorňák T, Král M, Hazlinger M, Herzig R, Veverka T, Buřval S, Šaňák D, Zapletalová J, Antalíková K, Kaňovský P. Int J Stroke; 2015 Dec; 10(8):1224-8. PubMed ID: 26310390 [Abstract] [Full Text] [Related]
18. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator. Chung JW, Kim KJ, Noh WY, Jang MS, Yang MH, Han MK, Kwon OK, Jung C, Kim JH, Oh CW, Lee JS, Lee J, Bae HJ. Cerebrovasc Dis; 2013 Dec; 35(5):461-8. PubMed ID: 23735898 [Abstract] [Full Text] [Related]
19. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study. Paciaroni M, Agnelli G, Caso V, Pieroni A, Bovi P, Cappellari M, Zini A, Nichelli P, Inzitari D, Nesi M, Nencini P, Pezzini A, Padovani A, Tassinari T, Orlandi G, Chiti A, Gialdini G, Alberti A, Venti M, Acciarresi M, D'Amore C, Luda E, Tassi R, Martini G, Ferrarese C, Beretta S, Trentini C, Silvestrelli G, Lanari A, Previdi P, Ciccone A, Delodovici ML, Bono G, Galletti G, Marcheselli S, Del Sette M, Traverso E, Riva M, Silvestrini M, Cerqua R, Consoli D, Monaco S, Toni D. Cerebrovasc Dis; 2012 Dec; 34(5-6):430-5. PubMed ID: 23207482 [Abstract] [Full Text] [Related]
20. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan. Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K. J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092 [Abstract] [Full Text] [Related] Page: [Next] [New Search]